Display Settings:

Format

Send to:

Choose Destination

    Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):417-8.

    Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.

    Pearce CL, Makridakis NM, Ross RK, Pike MC, Kolonel LN, Henderson BE, Reichardt JK.

    Department of Preventive Medicine and USC/Norris Comprehensive Cancer Center and Hospital, University of Southern California Keck School of Medicine, Los Angeles, California 90089-9176, USA.

    PMID: 11927504 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read